Literature DB >> 17143718

High-pressure irrigation and gentian-violet application for mediastinitis following replacement of ascending aorta and aortic valve.

Takayoshi Kato1, Hisato Takagi, Yukihiro Matsuno, Matsuhisa Imaizumi, Takuya Umemoto.   

Abstract

Mediastinitis following ascending aortic replacement is intractable and potentially fatal, and the feature is characterized as having both high mortality and morbidity when its causation pathology is methicillin-resistant Staphylococcus aureus (MRSA). Possible treatments for the condition, which include debridement, irrigation, and healthy tissue transposition, often result in failure. We report a case of MRSA mediastinitis after replacement of the ascending aorta and the aortic valve successfully treated by continuous saline lavage and drainage, debridement, high-pressure irrigation, and gentian-violet application, and delayed omental-flap transposition. The application of gentian violet and high-pressure irrigation may provide an additional option to the standard therapy for intractable mediastinitis after ascending aortic replacement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143718     DOI: 10.1007/s00380-006-0921-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  8 in total

1.  High-pressure saline washing of allografts reduces bacterial contamination.

Authors:  M Y Hirn; P M Salmela; R E Vuento
Journal:  Acta Orthop Scand       Date:  2001-02

Review 2.  Successful in situ treatment of an infected ascending aortic graft.

Authors:  D W Mathes; M J Yaremchuk; E M Isselbacher; J C Madsen
Journal:  Ann Thorac Surg       Date:  2000-10       Impact factor: 4.330

3.  Topical gentian violet for cutaneous infection and nasal carriage with MRSA.

Authors:  M Okano; S Noguchi; K Tabata; Y Matsumoto
Journal:  Int J Dermatol       Date:  2000-12       Impact factor: 2.736

4.  Methicillin-resistant Staphylococcus aureus disease in three communities.

Authors:  Scott K Fridkin; Jeffrey C Hageman; Melissa Morrison; Laurie Thomson Sanza; Kathryn Como-Sabetti; John A Jernigan; Kathleen Harriman; Lee H Harrison; Ruth Lynfield; Monica M Farley
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

5.  Gentian violet--is it safe?

Authors:  P Drinkwater
Journal:  Aust N Z J Obstet Gynaecol       Date:  1990-02       Impact factor: 2.100

6.  High-pressure wound irrigation.

Authors:  H Rogness
Journal:  J Enterostomal Ther       Date:  1985 Jan-Feb

Review 7.  Staphylococcus aureus. The persistent pathogen (second of two parts).

Authors:  J N Sheagren
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

8.  [Effect of gentiana violet against methicillin-resistant Staphylococcus aureus (MRSA)].

Authors:  M Saji
Journal:  Kansenshogaku Zasshi       Date:  1992-07
  8 in total
  3 in total

Review 1.  Gentian violet: a 19th century drug re-emerges in the 21st century.

Authors:  Alexander M Maley; Jack L Arbiser
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

2.  Treatment strategies for aortic and peripheral prosthetic graft infection.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Masatoshi Jibiki; Norihide Sugano; Yoshinori Inoue
Journal:  Surg Today       Date:  2013-04-05       Impact factor: 2.549

Review 3.  Prevention, Diagnosis and Management of Post-Surgical Mediastinitis in Adults Consensus Guidelines of the Spanish Society of Cardiovascular Infections (SEICAV), the Spanish Society of Thoracic and Cardiovascular Surgery (SECTCV) and the Biomedical Research Centre Network for Respiratory Diseases (CIBERES).

Authors:  Emilio Bouza; Arístides de Alarcón; María Carmen Fariñas; Juan Gálvez; Miguel Ángel Goenaga; Francisco Gutiérrez-Díez; Javier Hortal; José Lasso; Carlos A Mestres; José M Miró; Enrique Navas; Mercedes Nieto; Antonio Parra; Enrique Pérez de la Sota; Hugo Rodríguez-Abella; Marta Rodríguez-Créixems; Jorge Rodríguez-Roda; Gemma Sánchez Espín; Dolores Sousa; Carlos Velasco García de Sierra; Patricia Muñoz; Martha Kestler
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.